Helly N. Hammer

Bern, BE 3010, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Higher disease reactivation risk in women after fingolimod withdrawal.

Higher disease reactivation risk in women after fingolimod withdrawal.

Journal: Acta neuropathologica communications

Published: March 17, 2026

Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?

Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 06, 2025

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT).

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT).

Journal: Frontiers in digital health

Published: October 09, 2025

Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosis.

Monitoring physical activity by fitness tracking devices : Usage, acceptance and willingness to share data in patients with multiple sclerosis.

Journal: Wiener klinische Wochenschrift

Published: September 29, 2025

Sex differences in baseline characteristics, stroke care, and outcomes across socioeconomic settings: a multicentre study from Switzerland, Poland, and Ukraine.

Sex differences in baseline characteristics, stroke care, and outcomes across socioeconomic settings: a multicentre study from Switzerland, Poland, and Ukraine.

Journal: Journal of neurology

Published: August 13, 2025

Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study.

Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study.

Journal: Cureus

Published: July 16, 2025

7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine.

7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine.

Journal: European journal of neurology

Published: June 03, 2025

Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score.

Risk stratification for disease reactivation after therapy de-escalation/discontinuation in relapsing multiple sclerosis by the VIAADISC score.

Journal: Multiple sclerosis and related disorders

Published: November 29, 2024

Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.

Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.

Journal: European journal of neurology

Published: October 14, 2024

Paraneoplastic Tumefactive Demyelination With Underlying Anaplastic Thyroid Cancer: A Case Report and Review of the Literature.

Paraneoplastic Tumefactive Demyelination With Underlying Anaplastic Thyroid Cancer: A Case Report and Review of the Literature.

Journal: Journal of central nervous system disease

Published: September 27, 2024

Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.

Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.

Journal: Neurology

Published: August 28, 2024

Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.

Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.

Journal: BMC medicine

Published: August 22, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026